Latest news
Grifols Completes Clinical Portion of Phase 3 Trial of Prolastin-C in Emphysema - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 13:15:35 GMTGrifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:20 GMT